MedTrace Logo

Real Time Optical Coherence Tomography (OCT) of Human Tissue

NCT01506700 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2019-07-26

No results posted yet for this study

Summary

This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.

Conditions

Interventions

DEVICE

Optical Coherence Tomography

Optical coherence tomography will be used to image tissue structure on excised and in vivo specimens.

Sponsors & Collaborators

  • University of Illinois at Chicago

    collaborator OTHER

  • Diagnostic Photonics, Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen A Boppart, MD, PhD · University of Illinois and Diagnostic Photonics, Inc.

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-12-20
Completion
2019-07-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01506700 on ClinicalTrials.gov